Shah, N. P., Talpaz, M., Deininger, M. W. N., Mauro, M. J., Flinn, I. W., Bixby, D., . . . Cortes, J. E. (2013). Ponatinib in patients with refractory acute myeloid leukaemia: Findings from a phase 1 study.
Chicago-stil citatShah, Neil P., et al. Ponatinib in Patients With Refractory Acute Myeloid Leukaemia: Findings From a Phase 1 Study. 2013.
MLA-referensShah, Neil P., et al. Ponatinib in Patients With Refractory Acute Myeloid Leukaemia: Findings From a Phase 1 Study. 2013.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.